HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH) has 2 open-market insider trades by 2 insiders since 2006. The most active filer is Brendan McDonnell, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Brendan McDonnell | Dir | — | 1 | $57K | 2006-12-12 |
| Marc R. Sarni | Dir | — | 1 | $27K | 2006-12-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Robert W. Weber | Controller | Sell | $16K | 2007-03-05 |
| Eric J. Loumeau | VP & Corporate General Counsel | Sell | $5K | 2007-02-14 |
| Daniel D. Burgess | COO/CFO | Sell | $12K | 2007-02-14 |
| James M. Frincke | Chief Scientific Officer | Sell | $6K | 2007-02-13 |
| Robert W. Weber | Controller | Sell | $16K | 2007-02-05 |
| Robert W. Weber | Controller | Sell | $14K |
Companies that share insiders with HEPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2007-01-08 |
| Brendan McDonnell | Director | Buy | $57K | 2006-12-12 |
| Marc R. Sarni | Director | Buy | $27K | 2006-12-08 |
| Robert W. Weber | Controller | Sell | $5K | 2006-08-21 |
| Robert W. Weber | Controller | Sell | $114K | 2006-03-13 |
| Brendan McDonnell | Director | Sell | $31K | 2006-03-10 |
| Brendan McDonnell | Director | Sell | $37K | 2006-01-30 |